Literature DB >> 12871221

Role of chemokine ligand 2 in the protective response to early murine pulmonary tuberculosis.

Andre Kipnis1, Randall J Basaraba, Ian M Orme, Andrea M Cooper.   

Abstract

Chemokines play an important role in the development of immunity to tuberculosis. Chemokine ligand 2 (CCL2, JE, monocyte chemoattractant protein-1) is thought to be primarily responsible for recruiting monocytes, dendritic cells, natural killer cells and activated T cells, all of which play critical roles in the effective control of tuberculosis infection in mice. We show here that in mice in which the CCL2 gene was disrupted, low-dose aerosol infection with Mycobacterium tuberculosis resulted in fewer macrophages entering the lungs, but only a minor and transient increase in bacterial load in the lungs; these mice were still able to establish a state of chronic disease. Such animals showed similar numbers of activated T cells as wild-type mice, as determined by their expression of the CD44hi CD62lo phenotype, but a transient reduction in cells secreting interferon-gamma. These data indicate that the primary deficiency in mice unable to produce CCL2 is a transient failure to focus antigen-specific T lymphocytes into the infected lung, whereas other elements of the acquired host response are compensated for by different ligands interacting with the chemokine receptor CCR2.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12871221      PMCID: PMC1783002          DOI: 10.1046/j.1365-2567.2003.01680.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  23 in total

Review 1.  Chemokines and their receptors guiding T lymphocyte recruitment in lung inflammation.

Authors:  D D'Ambrosio; M Mariani; P Panina-Bordignon; F Sinigaglia
Journal:  Am J Respir Crit Care Med       Date:  2001-10-01       Impact factor: 21.405

Review 2.  A literature review of the problems of delayed presentation for treatment and non-completion of treatment for tuberculosis in less developed countries and ways of addressing these problems using particular implementations of the DOTS strategy.

Authors:  Cassie Thomas
Journal:  J Manag Med       Date:  2002

3.  T lymphocytes mediating protection and cellular cytolysis during the course of Mycobacterium tuberculosis infection. Evidence for different kinetics and recognition of a wide spectrum of protein antigens.

Authors:  I M Orme; E S Miller; A D Roberts; S K Furney; J P Griffin; K M Dobos; D Chi; B Rivoire; P J Brennan
Journal:  J Immunol       Date:  1992-01-01       Impact factor: 5.422

4.  Chemokine receptor 2 serves an early and essential role in resistance to Mycobacterium tuberculosis.

Authors:  W Peters; H M Scott; H F Chambers; J L Flynn; I F Charo; J D Ernst
Journal:  Proc Natl Acad Sci U S A       Date:  2001-07-03       Impact factor: 11.205

5.  Purification of a monocyte chemotactic factor secreted by nonhuman primate vascular cells in culture.

Authors:  A J Valente; D T Graves; C E Vialle-Valentin; R Delgado; C J Schwartz
Journal:  Biochemistry       Date:  1988-05-31       Impact factor: 3.162

6.  Adoptive protection of the Mycobacterium tuberculosis-infected lung. Dissociation between cells that passively transfer protective immunity and those that transfer delayed-type hypersensitivity to tuberculin.

Authors:  I M Orme; F M Collins
Journal:  Cell Immunol       Date:  1984-03       Impact factor: 4.868

7.  Mycobacterium tuberculosis in chemokine receptor 2-deficient mice: influence of dose on disease progression.

Authors:  Holly M Scott; JoAnne L Flynn
Journal:  Infect Immun       Date:  2002-11       Impact factor: 3.441

8.  Consensus statement. Global burden of tuberculosis: estimated incidence, prevalence, and mortality by country. WHO Global Surveillance and Monitoring Project.

Authors:  C Dye; S Scheele; P Dolin; V Pathania; M C Raviglione
Journal:  JAMA       Date:  1999-08-18       Impact factor: 56.272

9.  Tuberculosis drug resistance: a global threat.

Authors:  Jean B Nachega; Richard E Chaisson
Journal:  Clin Infect Dis       Date:  2003-01-15       Impact factor: 9.079

10.  The relative importance of T cell subsets in immunity and immunopathology of airborne Mycobacterium tuberculosis infection in mice.

Authors:  T Mogues; M E Goodrich; L Ryan; R LaCourse; R J North
Journal:  J Exp Med       Date:  2001-02-05       Impact factor: 14.307

View more
  33 in total

Review 1.  Beyond macrophages: the diversity of mononuclear cells in tuberculosis.

Authors:  Smita Srivastava; Joel D Ernst; Ludovic Desvignes
Journal:  Immunol Rev       Date:  2014-11       Impact factor: 12.988

2.  Contribution of transmembrane tumor necrosis factor to host defense against Mycobacterium bovis bacillus Calmette-guerin and Mycobacterium tuberculosis infections.

Authors:  Maria L Olleros; Reto Guler; Dominique Vesin; Roumen Parapanov; Gilles Marchal; Eduardo Martinez-Soria; Nadia Corazza; Jean-Claude Pache; Christoph Mueller; Irene Garcia
Journal:  Am J Pathol       Date:  2005-04       Impact factor: 4.307

Review 3.  Mycobacterium tuberculosis: Bacterial Fitness within the Host Macrophage.

Authors:  Lu Huang; Evgeniya V Nazarova; David G Russell
Journal:  Microbiol Spectr       Date:  2019-03

Review 4.  Monocyte trafficking in acute and chronic inflammation.

Authors:  Molly A Ingersoll; Andrew M Platt; Stephane Potteaux; Gwendalyn J Randolph
Journal:  Trends Immunol       Date:  2011-06-12       Impact factor: 16.687

5.  Diabetic mice display a delayed adaptive immune response to Mycobacterium tuberculosis.

Authors:  Therese Vallerskog; Gregory W Martens; Hardy Kornfeld
Journal:  J Immunol       Date:  2010-04-26       Impact factor: 5.422

Review 6.  Chemokines shape the immune responses to tuberculosis.

Authors:  Samantha R Slight; Shabaana A Khader
Journal:  Cytokine Growth Factor Rev       Date:  2012-11-16       Impact factor: 7.638

7.  Expression of the leptin receptor outside of bone marrow-derived cells regulates tuberculosis control and lung macrophage MHC expression.

Authors:  Maria P Lemos; Kyu Y Rhee; John D McKinney
Journal:  J Immunol       Date:  2011-08-22       Impact factor: 5.422

8.  Characterization of a novel necrotic granuloma model of latent tuberculosis infection and reactivation in mice.

Authors:  Noton K Dutta; Peter B Illei; Sanjay K Jain; Petros C Karakousis
Journal:  Am J Pathol       Date:  2014-05-09       Impact factor: 4.307

9.  The adaptor molecule CARD9 is essential for tuberculosis control.

Authors:  Anca Dorhoi; Christiane Desel; Vladimir Yeremeev; Lydia Pradl; Volker Brinkmann; Hans-Joachim Mollenkopf; Karin Hanke; Olaf Gross; Jürgen Ruland; Stefan H E Kaufmann
Journal:  J Exp Med       Date:  2010-03-29       Impact factor: 14.307

10.  CCL2 responses to Mycobacterium tuberculosis are associated with disease severity in tuberculosis.

Authors:  Zahra Hasan; Jacqueline M Cliff; Hazel M Dockrell; Bushra Jamil; Muhammad Irfan; Mussarat Ashraf; Rabia Hussain
Journal:  PLoS One       Date:  2009-12-29       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.